HALO

Halozyme Therapeutics, Inc. News Headlines

$8.77
*  
0.25
2.93%
Get HALO Alerts
*Delayed - data as of Nov. 24, 2014 9:58 ET  -  Find a broker to begin trading HALO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    HALO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Halozyme Therapeutics (HALO) Stock Is Slipping Today on Weak Third Quarter Earnings
11/11/2014 11:42:00 AM - TheStreet


Halozyme Therapeutics Plunge 12% As Q3 Results Miss Estimates
11/10/2014 8:51:00 PM - RTT News


Halozyme Loss Wider Than Estimate, Revenue Misses; Stock Down 8%
11/10/2014 4:57:00 PM - RTT News


First Week of HALO June 2015 Options Trading
10/27/2014 10:17:03 AM - BNK Invest


Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog
10/22/2014 4:54:00 PM - Zacks.com


Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog
10/22/2014 12:10:00 PM - Zacks.com


Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog
10/22/2014 10:40:00 AM - Zacks.com


NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog
10/21/2014 5:05:00 PM - Zacks.com


Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog
10/20/2014 5:35:00 PM - Zacks.com


Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape
10/20/2014 8:39:00 AM - Zacks.com


Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
10/17/2014 4:00:00 PM - Zacks.com


Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape
10/17/2014 8:39:00 AM - Zacks.com


What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape
10/17/2014 7:57:00 AM - Zacks.com


Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape
10/17/2014 7:51:00 AM - Zacks.com


MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape
10/16/2014 8:46:00 AM - Zacks.com


Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 10.7% - Tale of the Tape
10/16/2014 8:39:00 AM - Zacks.com


NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape
10/14/2014 8:46:00 AM - Zacks.com


Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5% - Tale of the Tape
10/14/2014 7:44:00 AM - Zacks.com


Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog
10/7/2014 4:40:00 PM - Zacks.com


Halozyme Therapeutics Announces Issuance Of New U.S. Patent - Quick Facts
10/7/2014 8:47:00 AM - RTT News


FDA Grants Orphan Drug Designation For Halozyme''s PEGPH20 - Quick Facts
10/3/2014 7:57:00 AM - RTT News


FDA Grants Orphan Drug Designation For Halozyme's PEGPH20 - Quick Facts
10/3/2014 7:57:00 AM - RTT News


2 Attractive Small Cap Biotech Stocks With Recent Insider Buying
9/29/2014 3:29:00 PM - Seeking Alpha


Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA - Analyst Blog
9/19/2014 4:20:00 PM - Zacks.com


Halozyme Therapeutics : SWOG To Resume Trial In Advanced Pancreatic Cancer Drug
9/18/2014 9:24:00 AM - RTT News